Selling and Marketing Expense in USD of Augmedix, Inc. from 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Augmedix, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2019 to Q2 2024.
  • Augmedix, Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $3.75M, a 41.5% increase year-over-year.
  • Augmedix, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $12.8M, a 29.8% increase year-over-year.
  • Augmedix, Inc. annual Selling and Marketing Expense for 2023 was $10.7M, a 15.1% increase from 2022.
  • Augmedix, Inc. annual Selling and Marketing Expense for 2022 was $9.28M, a 30.4% increase from 2021.
  • Augmedix, Inc. annual Selling and Marketing Expense for 2021 was $7.12M, a 61.9% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)

Augmedix, Inc. Quarterly Selling and Marketing Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $12.8M $3.75M +$1.1M +41.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $11.7M $3.56M +$1M +39% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $10.7M $2.75M +$407K +17.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $10.3M $2.73M +$425K +18.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $9.86M $2.65M +$329K +14.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $9.53M $2.56M +$243K +10.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $9.28M $2.34M +$555K +31.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $8.73M $2.3M +$269K +13.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $8.46M $2.32M +$592K +34.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $7.87M $2.32M +$746K +47.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $7.12M $1.78M +$331K +22.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 $6.79M $2.04M +$1.15M +129% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-18
Q2 2021 $5.64M $1.73M +$909K +111% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $4.73M $1.57M +$335K +27% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $4.4M $1.45M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $887K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $819K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $1.24M Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-06-30

Augmedix, Inc. Annual Selling and Marketing Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $10.7M +$1.4M +15.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 $9.28M +$2.16M +30.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $7.12M +$2.72M +61.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 $4.4M +$815K +22.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $3.58M Jan 1, 2019 Dec 31, 2019 10-K/A 2021-06-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.